Literature DB >> 11295320

Reducing the harms caused by cannabis use: the policy debate in Australia.

W Hall1.   

Abstract

The debate about cannabis policy in Australia has revolved around the harms that cannabis causes to users and the community, on the one hand, and the harms that are caused by the prohibition of its use, on the other. This paper assesses evidence on: (1) the harms caused to users and the community by cannabis use (derived from the international scientific literature) and (2) the harms that arise from prohibition (as reflected in Australian research). The most probable harms caused by cannabis use include: an increased risk of motor vehicle accidents; respiratory disease; dependence; adverse effects on adolescent development; and the exacerbation of psychosis. The harms of the current prohibition on cannabis use policy are less tangible but probably include: the creation of a large blackmarket; disrespect for a widely broken law; harms to the reputation of the unlucky few cannabis users who are caught and prosecuted; lack of access to cannabis for medical uses; and an inefficient use of law enforcement resources. Cannabis policy unavoidably involves trade offs between competing values that should be made by the political process. Australian cannabis policy has converged on a solution which continues to prohibit cannabis but reduces the severity of penalties for cannabis use by either removing criminal penalties or diverting first time cannabis offenders into treatment and education.

Entities:  

Mesh:

Year:  2001        PMID: 11295320     DOI: 10.1016/s0376-8716(00)00171-x

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  7 in total

Review 1.  Cannabis control: costs outweigh the benefits. For.

Authors:  Alex Wodak; Craig Reinarman; Peter D A Cohen; Colin Drummond
Journal:  BMJ       Date:  2002-01-12

2.  Gene-environment interplay in affect and dementia: emotional modulation of cognitive expression in personal outcomes.

Authors:  T Palomo; R J Beninger; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

3.  Progression in substance use initiation: A multilevel discordant monozygotic twin design.

Authors:  Leah S Richmond-Rakerd; Wendy S Slutske; Arielle R Deutsch; Michael T Lynskey; Arpana Agrawal; Pamela A F Madden; Kathleen K Bucholz; Andrew C Heath; Nicholas G Martin
Journal:  J Abnorm Psychol       Date:  2015-08

Review 4.  Role of endocannabinoid system in mental diseases.

Authors:  Jorge Manzanares; Leyre Urigüen; Gabriel Rubio; Tomás Palomo
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

5.  Evidence for Connections Between Prosecutor-Reported Marijuana Case Dispositions and Community Youth Marijuana-Related Attitudes and Behaviors.

Authors:  Yvonne M Terry-McElrath; Duane C McBride; Jamie F Chriqui; Patrick M O'Malley; Curtis J Vanderwaal; Frank J Chaloupka; Lloyd D Johnston
Journal:  Crime Delinq       Date:  2009-10

6.  Cannabinoids for the treatment of schizophrenia? A balanced neurochemical framework for both adverse and therapeutic effects of cannabis use.

Authors:  Carissa M Coulston; Michael Perdices; Antony F Henderson; Gin S Malhi
Journal:  Schizophr Res Treatment       Date:  2010-07-27

7.  Cannabis Liberalization and Adolescent Cannabis Use: A Cross-National Study in 38 Countries.

Authors:  Yuyan Shi; Michela Lenzi; Ruopeng An
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.